Menarini Silicon Biosystems

Join us at ISMRC 2025 – The Premier Congress on Liquid Biopsy & Circulating Biomarkers! We are honored to be attending ISMRC 2025, 7 - 9 May, the International Symposium on Minimal Residual Cancer, where leading experts from around the world will gather to discuss the latest breakthroughs in liquid biopsy, circulating biomarkers, and precision oncology. Looking forward to seeing you there! https://lnkd.in/evfAFv3K #ISMRC2025 #LiquidBiopsy #CancerResearch #PrecisionMedicine #CirculatingBiomarkers

We are excited to offer our unconditional contribution to the ECM course, Focus on TOP, happening this week in Udine. This event features presentations from leading global experts in oncology and aims to address the fast-evolving landscape of breast cancer management. With the shift toward personalized treatment approaches, the symposium will explore cutting-edge advancements in targeted therapies and biomarker development—including circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), next-generation sequencing, and multi-omics. These innovations highlight the importance of collaborative, interdisciplinary efforts to translate complex tools into meaningful clinical outcomes. More information is available at https://lnkd.in/gYQs-w6E #BreastCancer #CTC #FocusOnTop #PrecisionOncology #Oncology #CancerResearch #LiquidBiopsy

Don't miss your opportunity to join the live webinar and Q&A with Massimo Cristofanilli, MD, FACP, Professor of Medicine at Weill Cornell Medicine on March 12th (7PM EST) where he will present "Evaluation of HER2 Status on Peripheral Blood with CellSearch". Register Now! https://lnkd.in/gf6XCNAv #ctc #Cellsearch #HER2 #breastcancer #webinar

Today, we proudly recognize the 𝗶𝗻𝗰𝗿𝗲𝗱𝗶𝗯𝗹𝗲 𝘄𝗼𝗺𝗲𝗻 who drive innovation, inspire change, and shape the future of life sciences. At 𝗠𝗲𝗻𝗮𝗿𝗶𝗻𝗶 𝗦𝗶𝗹𝗶𝗰𝗼𝗻 𝗕𝗶𝗼𝘀𝘆𝘀𝘁𝗲𝗺𝘀, we are committed to fostering a workplace where equality, inclusion, and empowerment thrive. We celebrate the achievements of women in STEM while continuing to support the next generation of female leaders in healthcare and biotechnology. Join us in honoring the contributions of women everywhere. 💜 𝗛𝗮𝗽𝗽𝘆 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗗𝗮𝘆! 💜 #IWD2025 #InternationalWomensDay #WomenInSTEM #WomenInScience #MenariniSiliconBiosystems

March is Colorectal Cancer Awareness Month. At Menarini Silicon Biosystems we are committed to supporting health care providers with innovative tools to help monitor cancer progression and inform treatment decisions and we recognize our patient advocacy partners #FightCRC and the #ColorectalCancerAlliance for all the work they do to empower patients with knowledge and support. Together, we can raise awareness, advance the science, and improve outcomes for colorectal cancer patients. #ColorectalCancerAwareness #CancerCare #FightCRC #colorectalcanceralliance #MenariniSiliconBiosystems

Join us for a live webinar and Q&A with Massimo Cristofanilli, MD, FACP, Professor of Medicine at Weill Cornell Medicine on March 12th (7PM EST) where he will present "Evaluation of HER2 Status on Peripheral Blood with CellSearch". Save your spot today! https://lnkd.in/gf6XCNAv #ctc #Cellsearch #HER2 #breastcancer #webinar

March is Multiple Myeloma Awareness Month. The American Cancer Society estimates over 36,000 patients will be diagnosed with Multiple Myeloma in the United States in 2025. During this time we acknowledge the healthcare providers, researchers, caregivers, and advocacy organizations dedicated to improving the lives of patient's affected by this disease. Menarini Silicon Biosystems is proud to stand united and renew our commitment to this endeavor. #multiplemyeloma #myeloma #myelomaACTIONmonth #CMMC

In recognition of Rare Disease Day, Menarini Silicon Biosystem employees at our US-based headquarters, in Huntingdon Valley, PA, took part in creating a collective art piece to show MSB's support in raising awareness for rare diseases, including Multiple Myeloma. #rarediseaseday #shareyourcolors #multiplemyeloma

🌍 February is Cancer Prevention Month, and at Menarini Silicon Biosystems, we’re committed to spreading awareness about the power of prevention. Small actions—like healthy habits and regular screenings—can reduce cancer risks. Let’s prioritize prevention for a healthier future. #CancerPrevention #Menarini #HealthAwareness

Discover our global biopharma lab services leveraging the gold standard CELLSEARCH technology and MenariniSearch Comprehensive Genomic Profiles. Our unique menu of services include enumeration of Circulating Tumor Cells and phenotyping (HER2, PDL1, ER), enumeration of Circulating Melanoma Cells and Circulating Multiple Myeloma Cells, as well as pan-cancer comprehensive cell-free RNA (cfRNA) and cell-free DNA (cfDNA) profiles across all cancer types. Contact us to learn how we can support your clinical trial and research projects: https://lnkd.in/dvEHcNy9 #labservices #biopharma #CTCtesting #clinical trial #cfRNA #cfDNA #CGP